BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 31685720)

  • 1. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men.
    Irie J; Inagaki E; Fujita M; Nakaya H; Mitsuishi M; Yamaguchi S; Yamashita K; Shigaki S; Ono T; Yukioka H; Okano H; Nabeshima YI; Imai SI; Yasui M; Tsubota K; Itoh H
    Endocr J; 2020 Feb; 67(2):153-160. PubMed ID: 31685720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men.
    Yamaguchi S; Irie J; Mitsuishi M; Uchino Y; Nakaya H; Takemura R; Inagaki E; Kosugi S; Okano H; Yasui M; Tsubota K; Hayashi K; Yoshino J; Itoh H
    Endocr J; 2024 Feb; 71(2):153-169. PubMed ID: 38191197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide mononucleotide (NMN) intake increases plasma NMN and insulin levels in healthy subjects.
    Yamane T; Imai M; Bamba T; Uchiyama S
    Clin Nutr ESPEN; 2023 Aug; 56():83-86. PubMed ID: 37344088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults.
    Pencina KM; Lavu S; Dos Santos M; Beleva YM; Cheng M; Livingston D; Bhasin S
    J Gerontol A Biol Sci Med Sci; 2023 Jan; 78(1):90-96. PubMed ID: 35182418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial.
    Katayoshi T; Uehata S; Nakashima N; Nakajo T; Kitajima N; Kageyama M; Tsuji-Naito K
    Sci Rep; 2023 Feb; 13(1):2786. PubMed ID: 36797393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
    Yi L; Maier AB; Tao R; Lin Z; Vaidya A; Pendse S; Thasma S; Andhalkar N; Avhad G; Kumbhar V
    Geroscience; 2023 Feb; 45(1):29-43. PubMed ID: 36482258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside.
    Mateuszuk Ł; Campagna R; Kutryb-Zając B; Kuś K; Słominska EM; Smolenski RT; Chlopicki S
    Biochem Pharmacol; 2020 Aug; 178():114019. PubMed ID: 32389638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update.
    Song Q; Zhou X; Xu K; Liu S; Zhu X; Yang J
    Adv Nutr; 2023 Nov; 14(6):1416-1435. PubMed ID: 37619764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men.
    Igarashi M; Nakagawa-Nagahama Y; Miura M; Kashiwabara K; Yaku K; Sawada M; Sekine R; Fukamizu Y; Sato T; Sakurai T; Sato J; Ino K; Kubota N; Nakagawa T; Kadowaki T; Yamauchi T
    NPJ Aging; 2022 May; 8(1):5. PubMed ID: 35927255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects.
    Okabe K; Yaku K; Uchida Y; Fukamizu Y; Sato T; Sakurai T; Tobe K; Nakagawa T
    Front Nutr; 2022; 9():868640. PubMed ID: 35479740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain.
    Ramanathan C; Lackie T; Williams DH; Simone PS; Zhang Y; Bloomer RJ
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.
    Mills KF; Yoshida S; Stein LR; Grozio A; Kubota S; Sasaki Y; Redpath P; Migaud ME; Apte RS; Uchida K; Yoshino J; Imai SI
    Cell Metab; 2016 Dec; 24(6):795-806. PubMed ID: 28068222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAD
    Yoshino J; Baur JA; Imai SI
    Cell Metab; 2018 Mar; 27(3):513-528. PubMed ID: 29249689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women.
    Fukamizu Y; Uchida Y; Shigekawa A; Sato T; Kosaka H; Sakurai T
    Sci Rep; 2022 Aug; 12(1):14442. PubMed ID: 36002548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the biosynthesis of nicotinamide mononucleotide in Lactococcus lactis by heterologous expression of FtnadE.
    Kong LH; Liu TY; Yao QS; Zhang XH; Xu WN; Qin JY
    J Sci Food Agric; 2023 Jan; 103(1):450-456. PubMed ID: 36205212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of Nicotinamide Mononucleotide after Intravenous Injection in Normal and Ischemic Stroke Mice.
    Zheng SL; Wang DS; Dong X; Guan YF; Qi Q; Hu WJ; Hong C; Zhang C; Miao CY
    Curr Pharm Biotechnol; 2023; 24(2):299-309. PubMed ID: 35593333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia.
    Park JH; Long A; Owens K; Kristian T
    Neurobiol Dis; 2016 Nov; 95():102-10. PubMed ID: 27425894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of β-nicotinamide mononucleotide and nicotinamide adenine dinucleotide in Dendrobium officinale and congeneric species by UPLC-MS/MS].
    Liu XQ; Yang H; Zhao JY; Meng CX; Li C; Zhang D; Chen LM; Yan Y; Guo ZY; Wang ZM; Yi H
    Zhongguo Zhong Yao Za Zhi; 2021 Aug; 46(16):4034-4039. PubMed ID: 34467712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide mononucleotide (NMN) as an anti-aging health product - Promises and safety concerns.
    Nadeeshani H; Li J; Ying T; Zhang B; Lu J
    J Adv Res; 2022 Mar; 37():267-278. PubMed ID: 35499054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety evaluation after acute and sub-chronic oral administration of high purity nicotinamide mononucleotide (NMN-C®) in Sprague-Dawley rats.
    Cros C; Cannelle H; Laganier L; Grozio A; Canault M
    Food Chem Toxicol; 2021 Apr; 150():112060. PubMed ID: 33587977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.